Eosinophilia-myalgia syndrome in Canada.
Wilkins
K
K
Surveillance and Risk Assessment Division, Bureau of Chronic Disease Epidemiology, Ottawa, Ontario.
Wigle
D
D
D000328:Adult; D000368:Aged; D002170:Canada / Q000453:epidemiology; D004802:Eosinophilia / Q000139:chemically induced / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced / Q000453:epidemiology*; D010146:Pain / Q000139:chemically induced / Q000453:epidemiology*; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan